Evidence map›Paper›PMID 23126278›Full record

ArticleChemical research in toxicology2012

Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies.

Jishen Pan, Bisola Awoyemi, Zhuoli Xuan, Priya Vohra, Hsiang-Tsui Wang, Marcin Dyba, Emily Greenspan, Ying Fu, Karen Creswell, Lihua Zhang and 3 more

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action.International journal of environmental research and public health · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jishen PanLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
Bisola Awoyemi
Zhuoli Xuan
Priya Vohra
Hsiang-Tsui Wang
Marcin Dyba
Emily Greenspan
Ying Fu
Karen Creswell
Lihua Zhang
Deborah Berry
Moon-Shong Tang
Fung-Lung Chung
Georgetown University · USGeorgetown University Medical Center · USNew York University · USUniversity of Washington · US

Funding

TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
ENALS IN TUMORIGENESISR01CA043159 · NCI · INSTITUTE FOR CANCER PREVENTION · PI CHUNG, FUNG-LUNG · 1986 to 2010
$2.6M
Lipid-Peroxidation Induced Cyclic Adducts in HepatocarcinogenesisR01CA134892 · NCI · GEORGETOWN UNIVERSITY · PI CHUNG, FUNG-LUNG · 2009 to 2013
$2.1M
NCI NIH HHS CA043159NCI NIH HHS CA134892NCI NIH HHS R01 CA043159NCI NIH HHS R01 CA134892NCI NIH HHS T32 CA009686
6 · The paper itself

Abstract

Acrolein (Acr) is a ubiquitous environmental pollutant found in cigarette smoke and automobile exhaust. It can also be produced endogenously by oxidation of polyunsaturated fatty acids. The Acr-derived 1,N(2)-propanodeoxyguanosine (Acr-dG) adducts in DNA are mutagenic lesions that are potentially involved in human cancers. In this study, monoclonal antibodies were raised against Acr-dG adducts and characterized using ELISA. They showed strong reactivity and specificity toward Acr-dG, weaker reactivity toward crotonaldehyde- and trans-4-hydroxy-2-nonenal-derived 1,N(2)-propanodeoxyguanosines, and weak or no reactivity toward 1,N(6)-ethenodeoxyadenosine and 8-oxo-deoxyguanosine. Using these antibodies, we developed assays to detect Acr-dG in vivo: first, a simple and quick FACS-based assay for detecting these adducts directly in cells; second, a highly sensitive direct ELISA assay for measuring Acr-dG in cells and tissues using only 1 μg of DNA without DNA digestion and sample enrichment; and third, a competitive ELISA for better quantitative measurement of Acr-dG levels in DNA samples. The assays were validated using Acr-treated HT29 cell DNA samples or calf thymus DNA, and the results were confirmed by LC-MS/MS-MRM. An immunohistochemical assay was also developed to detect and visualize Acr-dG in HT29 cells as well as in human oral cells. These antibody-based methods provide useful tools for the studies of Acr-dG as a cancer biomarker and of the molecular mechanisms by which cells respond to Acr-dG as a ubiquitous DNA lesion.

Indexed as

AcroleinAir PollutantsAnimalsAntibodies, MonoclonalBiomarkersCells, CulturedChromatography, LiquidDNA AdductsEnzyme-Linked Immunosorbent AssayHT29 CellsHumansKeratinocytesMiceMice, Inbred BALB CMouthTandem Mass SpectrometryAcroleinAir PollutantsAntibodies, MonoclonalBiomarkersDNA Adducts

Identifiers

PMID23126278
PMCPMC3561715
OpenAlexW2041125182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.